✦ LIBER ✦

A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non–ST-elevation acute coronary syndromes

✍ Scribed by Robert M. Califf; John L. Petersen; Vic Hasselblad; Kenneth W. Mahaffey; James J. Ferguson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Unfractionated heparin dosing and risk o

✍ Chiara Melloni; Karen P. Alexander; Anita Y. Chen; L. Kristin Newby; Matthew T. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 348 KB

Safety and efficacy of enoxaparin vs. un

✍ M.A. Blazing; J.A. de Lemos; H.D. White 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Safety and Efficacy of Enoxaparin vs Unf

✍ Blazing, Michael A. 📂 Article 📅 2004 🏛 American Medical Association 🌐 English ⚖ 180 KB

PCV49 ENOXAPARIN VERSUS UNFRACTIONATED H

✍ A Syrov; S Zyryanov; YB Belousov 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Efficacy and bleeding complications amon

✍ J.L. Petersen; K.W. Mahaffey; V. Hasselbladet 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Randomized double-blind safety study of

✍ Marc Cohen; Pierre Théroux; Steven Borzak; Martin J. Frey; Harvey D. White; W. V 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB